WAM
OACCW

Weiss Asset Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Weiss Asset Management’s Portfolio OACCW Stock Details OACCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Buy
144,767
+79,907
+123% +$62.5K ﹤0.01% 468
2025
Q4 		$46.1K Buy
+64,860
New +$54.1K ﹤0.01% 551

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Weiss Asset Management's OACCW Position: Q1 2026 in Review

Weiss Asset Management increased its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) stake by 123% in Q1 2026, buying an estimated $62.5K and bringing the position to 144,767 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #468.

Weiss Asset Management first reported a position in OACCW in Q4 2025 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

  • Weiss Asset Management held 144,767 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $103K as of Q1 2026.
  • Weiss Asset Management bought 79,907 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $62.5K.
  • Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Weiss Asset Management's portfolio in Q1 2026, its #468 holding.
  • Weiss Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2025 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Weiss Asset Management's 13F filing for Q1 2026, filed 15 May 2026.